GLP-1 Agonist is typically intended for long-term use for chronic weight management, alongside continued lifestyle efforts
Understanding exactly whats happening, why its happening, and what you can do about it is the first step toward protecting your access to medication you depend on
It is reasonable to speculate that MASH resolution could lead to regression of liver fibrosis, a significant factor in major adverse liver outcomes (MALO) such as ascites, hepatic encephalopathy, variceal bleeding, liver transplantation or liver-related mortality
We'll get in touch with advice on how to best take your medicine and help you make the lifestyle changes you need to manage your weight over the long-term
doi: 10.1111/dom.14255, 93
Its anticancer activity further supports its potential for integrative applications in both oncological and neurodegenerative diseases (Plirat et al., 2023